Using ethanol to improve treatment for heart rhythm problems after heart attacks
VENOUS ETHANOL ABLATION IN ISCHEMIC VENTRICULAR TACHYCARDIA- VELVET TRIAL
This study is exploring a new way to treat ventricular tachycardia in people with heart issues by using ethanol to target specific veins in the heart, hoping to make treatments more effective and safer than the usual methods.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11064972 on NIH RePORTER |
What this research studies
This research investigates a new approach to treat ventricular tachycardia (VT) in patients with ischemic cardiomyopathy by delivering ethanol to specific veins in the heart. The goal is to improve the effectiveness of existing treatments, which often have limitations and require repeat procedures. By targeting the veins associated with arrhythmogenic sites, the study aims to reduce complications and enhance patient outcomes. Patients will be monitored to assess the safety and efficacy of this innovative technique compared to traditional methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with ischemic cardiomyopathy who experience refractory ventricular tachycardia.
Not a fit: Patients who do not have ischemic cardiomyopathy or those without ventricular tachycardia may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer treatments for patients suffering from life-threatening heart rhythm disorders.
How similar studies have performed: Previous studies have shown promising results with similar approaches, indicating potential for success in this novel treatment method.
Where this research is happening
Houston, United States
- Methodist Hospital Research Institute — Houston, United States (Active)
Researchers
- Principal investigator: Valderrabano, Miguel — Methodist Hospital Research Institute
- Study coordinator: Valderrabano, Miguel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.